Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3192
Selected: 0
NCT IDTitle
NCT00513123Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia
NCT00459524Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
NCT01827241Outcome of Colonoscopy Screening and Surveillance
NCT00476905Spectral Diagnosis of Cutaneous Malignancy
NCT02940496Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
NCT00254423Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia
NCT07193550A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
NCT00412542Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
NCT01193868RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy
NCT07147205Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine
NCT00513162Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
NCT03283046Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma
NCT05361551Stereotactic Liver Ablation Assisted With Intra-Arterial CT Hepatic Arteriography and Ablation Confirmation Software Assessment (STEREOLAB)
NCT01644591Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases
NCT06056323A Study of HB0045 Injection in Patients With Advanced Solid Tumors
NCT06066359Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma
NCT02603887Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
NCT00985400Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery
NCT01176604Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma
NCT00528034Lymphoscintigraphy in Patients With Vaginal Cancer
NCT06647134A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
NCT07227909NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
NCT06807593Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
NCT02405078Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
NCT00843219Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating
NCT05308407POWER UP: Participating Online While Exercising to Recover Using Play
NCT02802787Implementation and Evaluation of an Activity Program to Improve Quality of Life Outcomes in Women Diagnosed With Cancer
NCT01168921Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
NCT00477412Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma
NCT06616636A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
NCT00002844Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
NCT057559843D Printed Breast Models in the Surgical Management of Breast Cancer
NCT02483858Study of Oral PQR309 in Patients With Advanced Solid Tumors
NCT03892993Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
NCT00003714Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
NCT06308575A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma
NCT01582152Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma
NCT04778449Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
NCT00848289Genetic Susceptibility to Bladder Cancer
NCT05305950Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors
NCT07011550Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer
NCT00047489Study of ABT-751 in Patients With Refractory Hematologic Malignancies
NCT0132078718-F-Fluoroacetate as PET Imaging Agent
NCT03458676Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
NCT01200004Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide
NCT03217747Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies
NCT00954226Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer
NCT04432506Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma
NCT00936858RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
NCT00776958Lynne Cohen Consortium Project: Multi-Center Database/Registry